Isolated Spleen Metastases of Endometrial Cancer: A Case Report

Background: Isolated splenic metastases from endometrial cancer, which is a relatively common malignancy, are extremely rare findings; to date, only 14 cases have been reported in the literature. Case Summary: We report a patient with isolated splenic metastases of endometrial cancer 3 years after r...

Descripción completa

Detalles Bibliográficos
Autores principales: Stojanovic, Marko M., Brzački, Vesna, Zivadinovic, Jelena D., Ignjatovic, Nebojsa S., Gmijovic, Marko D., Djordjevic, Miodrag N., Golubovic, Ilija, Nikolić, Nada G., Bojanic, Novica Z., Stojanovic, Miroslav P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145639/
https://www.ncbi.nlm.nih.gov/pubmed/35630009
http://dx.doi.org/10.3390/medicina58050592
Descripción
Sumario:Background: Isolated splenic metastases from endometrial cancer, which is a relatively common malignancy, are extremely rare findings; to date, only 14 cases have been reported in the literature. Case Summary: We report a patient with isolated splenic metastases of endometrial cancer 3 years after radical surgery of the primary tumor. The patient was successfully treated by splenectomy and six cycles of paclitaxel. Fifty months after splenectomy, she was alive and well, and with no evidence of disease. Conclusion: Isolated spleen metastasis of endometrial cancer is very rare. Radical surgery and adjuvant therapy may offer excellent long-term survival.

Ejemplares similares